US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.91

+0.25501.37%

Post-market: 18.910.00000.00%16:10 EDT

Volume:10.43K

Turnover:195.98K

Market Cap:109.70M

PE:- -

High:18.91

Open:18.83

Low:18.67

Close:18.66

52wk High:21.88

52wk Low:14.38

Shares:5.80M

Float Shares:5.80M

Volume Ratio:0.35

T/O Rate:0.18%

Dividend:0.71

Dividend Rate:3.78%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

China's Clover Biopharma H1 Revenue Drops Sharply, Flags Going-Concern Doubt

Akeso - Harmoni-Gi1 First Phase Iii Study to Show Significant Os Benefit Versus Global Standard in Biliary Tract Cancer

THOMSON REUTERS

Ivonescimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer: Harmoni-Gi1 Meets Primary Endpoint

THOMSON REUTERS

Akeso - Study Meets Key Secondary Endpoints of Progression-Free Survival and Objective Response Rate

THOMSON REUTERS

WuXi Biologics (Cayman) (SEHK:2269) Shares Climbed, So What Is Driving Attention Now?

Simply Wall St.

WuXi XDC Grants 342,300 Restricted Shares to Employees Under 2024 Share Scheme

China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales

WuXi Biologics Reports Strong Profitable Growth in H1 2026

THOMSON REUTERS

WuXi Biologics H1 Net Profit up on Margin Expansion

Wuxi Bio's Interim Results Exceed Expectations and Break Broker Targets, with Accelerated Manufacturing Growth Reinforcing Long-Term Investment Thesis

Market Sentiment Stabilizes as Sanctions Prove Largely Symbolic; Tech Benchmarks Surge on Potential Dovish Fed Signals

CSPC Pharma's Recombinant RSV Vaccine Wins US Clinical Trial Clearance

CSPC Says FDA Clears RSV Vaccine Candidate SYS 6057 for US Clinical Trial

CSPC Pharmaceutical - Recombinant Respiratory Syncytial Virus Vaccine (Sys6057) Obtains Clinical Trial Approval in U.S.

THOMSON REUTERS

CSPC Pharmaceutical - Sys6057 Receives Nmpa Approval on July 30, 2026 to Conduct Clinical Trials in China

THOMSON REUTERS

Innovent Biologics' H1 Profit Jumps 50%

MT Newswires Live

Innovent Biologics - Re-Designates Ronald Hao Xi Ede as Non-Executive Director Effective September 1, 2026

THOMSON REUTERS

WuXi Biologics Posts Higher Adjusted Attributable Profit in H1

MT Newswires Live

Innovent Announces 2026 Interim Results and Business Updates

THOMSON REUTERS

INNOVENT BIO Reports First-Half Profit of RMB 1.253 Billion, Up 50.2% Year-on-Year

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/KURE/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.91,"timestamp":1788465600000,"preClose":18.655,"halted":0,"volume":10429,"hourTrading":{"tag":"盘后","latestPrice":18.91,"preClose":18.91,"latestTime":"16:10 EDT","volume":10,"amount":189.1,"timestamp":1788466205561,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.013669257571696541,"floatShares":5800979,"shares":5800979,"eps":0,"marketStatus":"Post-Mkt","change":0.255,"latestTime":"09-03 16:15:54 EDT","open":18.83,"high":18.91,"low":18.6655,"amount":195976,"amplitude":0.013106,"askPrice":20.61,"askSize":100,"bidPrice":17.09,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788480000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":18.655,"sharesOutstanding":4750002,"nav":18.46,"aum":108936686.05,"dividendRate":0.0378,"bidAskSpread":0.00342,"postHourTrading":{"tag":"盘后","latestPrice":18.91,"preClose":18.91,"latestTime":"16:10 EDT","volume":10,"amount":189.1,"timestamp":1788466205561,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.349371,"impliedVol":0.2767,"impliedVolPercentile":0.5754},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5800979,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.349371,"shares":5800979,"dividePrice":0.7148,"high":18.91,"amplitude":0.013106,"preClose":18.655,"low":18.6655,"week52Low":14.3797,"pbRate":"--","week52High":21.875,"institutionHeld":0,"latestPrice":18.91,"eps":0,"divideRate":0.0378,"volume":10429,"delay":0,"ttmEps":0,"open":18.83,"prevYearClose":17.04,"prevWeekClose":18.925,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":19.215,"twentyDayClose":17.47,"sixtyDayClose":14.5156},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662505547","title":"China's Clover Biopharma H1 Revenue Drops Sharply, Flags Going-Concern Doubt","url":"https://stock-news.laohu8.com/highlight/detail?id=2662505547","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662505547?lang=en_us&edition=fundamental","pubTime":"2026-08-26 06:24","pubTimestamp":1787696645,"startTime":"0","endTime":"0","summary":"China's Clover Biopharma H1 revenue drops sharply, flags going-concern doubtOverviewChina vaccine developer's H1 revenue dropped sharply after ending AdimFlu-S (QIS) sales in ChinaCompany swung to net","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M103:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","LU0244354667.USD","LU2097828631.EUR","LU0455707207.USD","LU2488822045.USD","LU1188198961.HKD","LU2097828557.USD","LU2097828805.USD","LU2328871848.SGD","01801","LU2097828714.EUR","HK0000165453.HKD","BK1589","LU2097828474.EUR","LU2242644610.SGD","LU0463099449.HKD","LU0326950275.SGD","06118","BK1161","KURE","02197","BK1141","LU0502904849.HKD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752407","title":"Akeso - Harmoni-Gi1 First Phase Iii Study to Show Significant Os Benefit Versus Global Standard in Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752407","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662752407?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA5XV27P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0348766576.USD","IE00BPRC5H50.USD","LU0540923850.HKD","LU2476274720.SGD","LU0634319403.HKD","BK1161","LU0348825331.USD","IE00B543WZ88.USD","LU2488822045.USD","LU0561508036.HKD","LU0348827113.USD","BK1574","LU0417516738.SGD","LU2399975544.HKD","LU1961090484.USD","LU2476274308.USD","LU0417516571.SGD","IE00B5MMRT66.SGD","KURE","LU0348783233.USD","LU2778985437.USD","LU0348784397.USD","LU0348735423.USD","LU1720050803.USD","LU0348767384.USD","LU1794554557.SGD","09926","LU0417516902.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662524007","title":"Ivonescimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer: Harmoni-Gi1 Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2662524007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662524007?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA5XV27P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09926","KURE","LU0348767384.USD","LU0417516738.SGD","IE00BPRC5H50.USD","LU0348766576.USD","LU0417516902.SGD","LU1794554557.SGD","LU2476274720.SGD","LU0634319403.HKD","LU0561508036.HKD","BK1574","LU0348784397.USD","LU0540923850.HKD","LU2399975544.HKD","LU2778985437.USD","LU0348783233.USD","LU0348735423.USD","IE00B5MMRT66.SGD","LU0348825331.USD","BK1161","LU1961090484.USD","IE00B543WZ88.USD","LU1720050803.USD","LU2476274308.USD","LU2488822045.USD","LU0348827113.USD","LU0417516571.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662401752","title":"Akeso - Study Meets Key Secondary Endpoints of Progression-Free Survival and Objective Response Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2662401752","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662401752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA5XV27P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1961090484.USD","LU0417516738.SGD","LU0561508036.HKD","BK1574","IE00BPRC5H50.USD","LU2488822045.USD","LU0348825331.USD","LU0348784397.USD","LU0348827113.USD","LU0417516571.SGD","LU0417516902.SGD","09926","LU2778985437.USD","LU2476274308.USD","LU1720050803.USD","LU0634319403.HKD","LU0348783233.USD","LU0348766576.USD","LU2399975544.HKD","LU0348735423.USD","LU1794554557.SGD","IE00B543WZ88.USD","BK1161","LU2476274720.SGD","LU0540923850.HKD","KURE","LU0348767384.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662068756","title":"WuXi Biologics (Cayman) (SEHK:2269) Shares Climbed, So What Is Driving Attention Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662068756","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662068756?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:22","pubTimestamp":1787674955,"startTime":"0","endTime":"0","summary":"WuXi Biologics (Cayman) half year earnings in focus\nWuXi Biologics (Cayman) (SEHK:2269) reported half year 2026 earnings, noting higher sales, net income and earnings per share compared with the same period in 2025.\nSee our latest analysis for WuXi Biologics (Cayman).\nAlongside these half year results, WuXi Biologics (Cayman) has seen strong recent momentum, with a 30 day share price return of 33.5% and a 90 day share price return of 54.99%, while the 1 year total shareholder return is...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-cayman-sehk2269-shares-climbed-so-what-is-dri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-cayman-sehk2269-shares-climbed-so-what-is-dri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1576","IE00B0JY6N72.USD","LU1720050803.USD","KURE","LU0516422952.EUR","LU0708995583.HKD","LU0516422366.SGD","LU1688375341.USD","LU1242518931.SGD","LU0128526141.USD","LU0140636845.USD","LU0327786744.USD","BK1141","LU0823426308.USD","LU1794554557.SGD","LU0856984785.SGD","LU2039709279.SGD","SG9999002463.SGD","LU0456846285.SGD","LU0823426480.USD","LU0307460666.USD","LU0348825331.USD","SG9999002562.SGD","LU0181495838.USD","LU0456827905.SGD","BK1521","LU0359201612.USD","LU0359202008.SGD","BK1589","LU0029874061.USD","LU0417516902.SGD","BK1610","LU0052750758.USD","LU0326950275.SGD","LU0819121731.USD","LU1242518857.USD","LU3063872942.SGD","LU0043850808.USD","LU0516422440.USD","LU1880383366.USD","LU0588546209.SGD","02269","LU0417516738.SGD","LU0572944931.SGD","LU0979878070.USD","LU0320764599.SGD","LU0516423174.USD","LU0039217434.USD","LU0051755006.USD","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662307867","title":"WuXi XDC Grants 342,300 Restricted Shares to Employees Under 2024 Share Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2662307867","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662307867?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:55","pubTimestamp":1787666130,"startTime":"0","endTime":"0","summary":"WuXi XDC grants 342,300 restricted shares to employees under 2024 share schemeWuxi XDC Cayman granted 342,300 restricted shares to 13 employees under its 2024 Share Scheme on Aug. 25, 2026.Purchase pr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL4q2gL5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0181495838.USD","BK1576","LU2039709279.SGD","LU2488822045.USD","LU0516422440.USD","LU0456827905.SGD","LU0819121731.USD","KURE","LU1720050803.USD","LU1794554557.SGD","LU0417516902.SGD","LU0359202008.SGD","LU1880383366.USD","LU1242518931.SGD","SG9999002562.SGD","LU0708995583.HKD","LU0359201612.USD","LU0516423091.SGD","LU0348735423.USD","BK1141","LU0307460666.USD","LU0039217434.USD","BK1610","LU0029874061.USD","LU0320764599.SGD","SG9999014674.SGD","LU3063872942.SGD","LU0856984785.SGD","BK1521","BK1589","LU0516422366.SGD","LU0348825331.USD","SG9999002463.SGD","02268","LU0572944931.SGD","LU0326950275.SGD","LU0516423174.USD","02269","LU0823426308.USD","LU0417516738.SGD","LU0051755006.USD","IE00B0JY6N72.USD","LU1688375341.USD","LU0043850808.USD","LU0052750758.USD","LU0979878070.USD","LU0516422952.EUR","LU0140636845.USD","LU0823426480.USD","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732450","title":"China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732450","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732450?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:48","pubTimestamp":1787662122,"startTime":"0","endTime":"0","summary":"China's Innovent Biologics H1 revenue, profit rise on strong product salesOverviewChina biopharma firm's H1 revenue rose 44.8% yr/yr on strong product sales growthNet profit for H1 grew 50.2% yr/yr, s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0DS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","IE00B3PB1722.GBP","ABBV","IE00BGHQF631.EUR","LU0942090050.USD","LU1037948541.HKD","FHLC","BK0239","LU2097828805.USD","LU0234572021.USD","LU1551013342.USD","IE0002141913.USD","LU2089283258.USD","IYH","LU2148510915.USD","LU0203345920.USD","LU1732800096.USD","LU2097828631.EUR","TRUH","LU0170899867.USD","GLAM","IE00BVYPNW00.USD","LU0029864427.USD","IXJ","MEDX","AGNG","01911","LU0455707207.USD","PPH","IE00BLSP4452.SGD","IE00B42XCP33.USD","VHT","688331","PJP","01801","JDOC","KURE","SG9999015986.USD","XLV","IE000MB6IJN5.SGD","LU0456855351.SGD","FTXH","LU1496350171.SGD","LU2237443895.HKD","LU0098860793.USD","LU0965509283.SGD","RXL","LU1989772840.SGD","01167","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662321107","title":"WuXi Biologics Reports Strong Profitable Growth in H1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662321107","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662321107?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:46","pubTimestamp":1787661974,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUACBTSBQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1688375341.USD","BK1589","LU0456846285.SGD","LU1242518931.SGD","LU0456827905.SGD","BK1610","LU2039709279.SGD","LU0052750758.USD","SG9999002562.SGD","LU0140636845.USD","LU0029874061.USD","LU0326950275.SGD","LU0708995583.HKD","LU0039217434.USD","IE00B0JY6N72.USD","BK1141","LU0181495838.USD","LU0307460666.USD","LU0516423174.USD","BK1576","LU0348825331.USD","LU0359202008.SGD","LU0051755006.USD","SG9999002463.SGD","LU3063872942.SGD","LU0572944931.SGD","02269","LU0856984785.SGD","LU1880383366.USD","LU0516423091.SGD","LU0128526141.USD","LU0417516902.SGD","LU0516422952.EUR","LU0327786744.USD","LU1242518857.USD","LU0516422440.USD","KURE","LU0417516738.SGD","BK1521","LU0516422366.SGD","LU0320764599.SGD","LU0979878070.USD","LU0819121731.USD","LU0043850808.USD","LU0348735423.USD","LU0588546209.SGD","LU1720050803.USD","LU0359201612.USD","LU0823426308.USD","LU1794554557.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732647","title":"WuXi Biologics H1 Net Profit up on Margin Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732647","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732647?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:41","pubTimestamp":1787661670,"startTime":"0","endTime":"0","summary":"WuXi Biologics H1 net profit up on margin expansionOverviewChina biologics CDMO's H1 revenue grew 18% yr/yr, net profit attributable up 4%Gross profit margin expanded to 46.2% from 42.7%Growth driven ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0DX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","XLV","PPH","KURE","LU0289961442.SGD","MEDX","BK1141","LU2133065610.SGD","VHT","LU0949170772.SGD","LU0965509010.AUD","PJP","IXJ","LU2087621335.USD","LU2237443978.SGD","02269","TRUH","LU0211327993.USD","SG9999015952.SGD","LU1839511570.USD","SG9999001440.SGD","688331","RXL","IE0002270589.USD","LU0198837287.USD","LU1934455863.HKD","LU0234572021.USD","LU1983299246.USD","LU1496350502.SGD","LU1670627923.USD","FTXH","JDOC","LU0708994859.HKD","LU2112291526.USD","IE000F7OJYX1.SGD","ABBV","FHLC","GLAM","LU0234570918.USD","LU0052750758.USD","LU1496350171.SGD","SG9999015945.SGD","AGNG","IE00BN8TJ469.HKD","SG9999003800.SGD","IYH","LU1057294990.SGD","LU1989772923.USD","BK4533","LU1794554557.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157695314","title":"Wuxi Bio's Interim Results Exceed Expectations and Break Broker Targets, with Accelerated Manufacturing Growth Reinforcing Long-Term Investment Thesis","url":"https://stock-news.laohu8.com/highlight/detail?id=1157695314","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157695314?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:37","pubTimestamp":1787661431,"startTime":"0","endTime":"0","summary":"Amid recent pressure on the US dollar's credit profile and increased allocation momentum for Hong Kong-listed equities, Hong Kong's pharmaceutical sector has demonstrated a notable new-high effect...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320764599.SGD","LU0128526141.USD","LU0456846285.SGD","LU1720050803.USD","SG9999002463.SGD","BK1521","LU0417516902.SGD","LU3063872942.SGD","LU1242518857.USD","LU0029874061.USD","LU0516422952.EUR","LU0327786744.USD","LU0140636845.USD","LU1880383366.USD","LU1794554557.SGD","LU2039709279.SGD","LU0181495838.USD","LU0572944931.SGD","LU1242518931.SGD","IE00B0JY6N72.USD","BK1589","LU0039217434.USD","LU0307460666.USD","BK1610","SG9999002562.SGD","LU0051755006.USD","LU0348825331.USD","LU0823426480.USD","LU0043850808.USD","LU0359202008.SGD","BK1576","LU0516422440.USD","LU0708995583.HKD","LU0516423091.SGD","LU0516422366.SGD","LU0856984785.SGD","LU0326950275.SGD","LU0052750758.USD","LU0456827905.SGD","LU0819121731.USD","BK1141","KURE","LU0417516738.SGD","LU0823426308.USD","LU1688375341.USD","LU0348735423.USD","LU0516423174.USD","LU0588546209.SGD","LU0979878070.USD","LU0359201612.USD","02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102179577","title":"Market Sentiment Stabilizes as Sanctions Prove Largely Symbolic; Tech Benchmarks Surge on Potential Dovish Fed Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=1102179577","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102179577?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:03","pubTimestamp":1787659392,"startTime":"0","endTime":"0","summary":"Market dynamics took a surprising turn today as the harsh \"devastating\" sanctions threatened by the U.S. yesterday turned out to be more bark than bite. A-shares closed higher while Hong Kong stocks...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1852331112.SGD","SMH","SG9999001424.SGD","SG9999014559.SGD","NVDU","LU0823434740.USD","ESUM","LU0069063385.USD","LU2471134796.USD","LU0630378429.USD","BK4614","BK4551","LU2471134523.USD","LU0211328371.USD","BK4581","LU2272731865.HKD","LU0251143458.SGD","LU0880133367.SGD","LU2461242641.AUD","01548","01316","LU2476274308.USD","SG9999014906.USD","LU1267930490.SGD","LU2294711713.HKD","BK4548","LU2351347302.SGD","SG9999004220.SGD","LU1691799644.USD","01057","LU0516423174.USD","SG9999014898.SGD","LU0724617625.USD","BIDU","LU0215105999.USD","LU1400636491.USD","ONLN","CHAT","CLIX","LU2237443465.HKD","LU2487616109.SGD","IE00BMPRXR70.SGD","LU2456880835.USD","BK1516","LU0077335932.USD","BK4605","BK4505","LU1496350502.SGD","LU0197773673.USD","LU0072462343.USD","BK1521","LU2756315664.SGD","ROM","LU1861220033.SGD","LU2488822045.USD","LU1880398554.USD","ANV","LU2290526834.HKD","LU0289961442.SGD","SGXZ51526630.SGD","LU0797268264.HKD","BBYY","BK1574","NVC","LU0820561818.USD","LU1917777945.USD","IE0034235188.USD","BK4543","LU0494093205.USD","IE00BFSS8Q28.SGD","LU0157215616.USD","LU0965508806.USD","01888","NVDQ","LU2471134879.HKD","LU0326950275.SGD","LU0133085943.USD","LU2065170008.USD","LU0856984785.SGD","LU1623119135.USD","LU2491049909.HKD","LU0683600562.USD","LU0823414478.USD","LU2237957811.SGD","LU1935042488.USD","LU2360032135.SGD","LU2249611893.SGD","LU1115378108.SGD","LU0488056044.USD","LU2896262040.SGD","SNPE","IE00BWXC8680.SGD","SG9999015952.SGD","LU0227179875.USD","TYLG","LU1951200564.SGD","LU1282648689.USD","06869","LU0456842615.SGD","LU0661504455.SGD","BK1132","LU1366333091.USD","NVD","002703","LU1923622614.USD","LU2602419157.SGD","LU0417516738.SGD","HK0000304805.HKD","IE00BKVL7J92.USD","HK0000320264.USD","LU2083900584.USD","BK4550","LU1934455194.USD","TEK","LU0348825331.USD","LU0882574139.USD","SGXZ80539844.SGD","LU1232071149.USD","LU2108987350.USD","LU1934455277.USD","LU2264538146.SGD","LU0823414551.USD","LU1267930227.SGD","IE0004091025.USD","LU1037948541.HKD","SG9999014880.SGD","LU0310800379.SGD","LU2242649171.HKD","LU1244550221.USD","09888","BK4579","LU0345770993.USD","LU1688375341.USD","LU1282649141.HKD","LU1035775433.USD","IE00BYXW3230.USD","LU2360107168.USD","HK0000914660.USD","LU0417517546.SGD","LU2125909759.SGD","LU0868494708.USD","LU0327786744.USD","KBAB","07388","TRFK","LU0072462426.USD","SG9999014542.SGD","LU0823421416.USD","LU2236285917.USD","LU0395794307.EUR","BK4585","LU0795875169.SGD","IE00B4YYXB79.USD","BK4567","LU0819121731.USD","LU2125909247.SGD","LU1023057109.AUD","KBDCY","LU1064131342.USD","LU1242518857.USD","LU2191332357.HKD","LU0642271901.SGD","LU1048588211.SGD","LU1435385759.SGD","BK1576","LU0957791311.USD","LU1989764664.SGD","LU0274383008.USD","LU0029874061.USD","LU0345768153.USD","LU0788109477.HKD","LU1732799900.SGD","SOXQ","GAMR","IE000W1ABFV2.USD","AIPI","LU0572944931.SGD","LU0456846285.SGD","LU1066051811.HKD","LU1051769294.HKD","LU1144417596.USD","NVDL","LU0353189763.USD","LU2247934214.USD","LU1323610961.USD","BK1587","LU2361044949.HKD","LU0912757837.SGD","LU0640798160.USD","IE00B5TLWC47.USD","LU0545039389.USD","LU1267930730.SGD","LU2237443382.USD","LU0345770308.USD","LU0708995401.HKD","BK4558","SHOC","AIFD","LU1244550577.SGD","LU2168564222.USD","LU2746668461.USD","LU2347655073.USD","LU0417516902.SGD","IE0034235303.USD","SG9999014914.USD","LU0127658192.USD","LU0289960550.SGD","LU0823426480.USD","BK4565","LU0081259029.USD","LU1496350171.SGD","LU0203201768.USD","LU0762540952.USD","LU1769817179.HKD","LU0323591593.USD","BK1518","BK4529","LU0323240290.USD","00148","LU1808992512.USD","LU2100268510.USD","LU0820561909.HKD","BK1109","LU0456827905.SGD","SPTE","IE000KEQY171.SGD","LU1571399168.USD","LU2063271972.USD","LU2092627202.USD","LU1211504680.USD","IE00BD6J9T35.USD","LU0234570918.USD","IE000ITXATA3.USD","IE0003U64NQ7.SGD","IE0034224299.USD","LU0466842654.USD","LU1831875114.USD","NVDA","SNVD.UK","BK1506","AGOX","LU1823568750.SGD","IE00B7KXQ091.USD","LU0229945570.USD","LU0094547139.USD","LU0096362180.USD","LU0787776722.HKD","BK4534","LU2271345857.HKD","LU2430703178.SGD","LU1815336760.USD","LU0052750758.USD","LU2458330243.SGD","SG9999002828.SGD","LU0057025933.USD","LU2505996509.AUD","LU1815333072.USD","LU2357305700.SGD","LU1202635105.USD","LU2999663052.SGD","MCHS","LU2272731600.USD","IE00B4JS1V06.HKD","BK1609","LU2213496289.HKD","09995","LU2750360641.GBP","LU1328615791.USD","LU0109392836.USD","LU1127390331.HKD","LU0143551892.USD","LU0942090050.USD","SG9999014567.USD","USXF","LU2097344357.USD","SNVDA2609","LU1008478684.HKD","IE00B19Z8X17.USD","LU1244550494.USD","LU2328871848.SGD","LU2357125470.USD","SOXY","LU0228367735.SGD","IE00BDCRKT87.USD","LU0225283273.USD","LU0965509283.SGD","LU2552382132.HKD","LU1551013425.SGD","LU1235294995.USD","LU1992135472.HKD","BK1095","LU0124676726.USD","LU1935043536.SGD","688428","LU2360106780.USD","HK0000320223.HKD","LU1152091754.HKD","LU0315179316.USD","LU1066053197.SGD","LU1720051108.HKD","LU0871576103.HKD","LU2187417386.USD","LU0726765562.USD","LU2491050071.SGD","LU1699723380.USD","LU0943347566.SGD","EFIV","LU1242518931.SGD","LU2265009873.SGD","TCHI","LU0067412154.USD","IE00B5949003.HKD","IE00BQXX3C00.GBP","HK0000306701.USD","LU0203202063.USD","LU2047632596.USD","NVDX","SG9999015341.SGD","2NVD.UK","LU0107464264.USD","IE0005OL40V9.USD","LU0516422952.EUR","LU0354030511.USD","ESLG","LU0511384066.AUD","SG9999002463.SGD","09988","CLSE","LU1400636657.SGD","LU0310800965.SGD","IE00B3M56506.USD","06821","NVDG","NVDS","LU0348723411.USD","LU0175139822.USD","LU2089985449.USD","SGXZ31699556.SGD","LU1048596156.SGD","LU0347712357.USD","LU1084165304.USD","LU0029864427.USD","SGXZ99366536.SGD","LU0210536198.USD","LU2065171402.SGD","BK1161","LU1066051498.USD","BK4608","BK4141","LU2552382215.SGD","09969","LU0079474960.USD","LU1732800096.USD","BK4554","LU0158827781.USD","LU0345768740.USD","LU0348816934.USD","DRAG","LU2347655156.SGD","BK4502","BABO","LU0043850808.USD","LU0061475181.USD","LU0163747925.USD","LU0965509010.AUD","LU1988902786.USD","IE00B775H168.HKD","HK0000304797.USD","LU2473716301.USD","BK1519","LU1814569148.SGD","LU2491050154.USD","IE0009356076.USD","LU0106959298.USD","LU0708995583.HKD","IE000Q6AESB8.SGD","LU1145028129.USD","LU0096364046.USD","LU0861579265.USD","LU1868836757.USD","IE00BK4W5M84.HKD","LU0342679015.USD","SGXZ23171101.USD","IE0004445239.USD","LU0051755006.USD","LU0244354667.USD","IE00B19Z9505.USD","LU1868837136.USD","NVDO","LU1551013342.USD","LU0384037296.USD","LU1267930573.SGD","LU2286300806.USD","LU2092937148.SGD","LU0672654240.SGD","NVDW","LU2505996681.GBP","LU0354030438.USD","LU0979878070.USD","LU1119994496.HKD","LU0198837287.USD","LU0516422440.USD","BK1149","LU2097344431.USD","LU2860962120.EUR","LU2087621335.USD","BK4122","LU1791710400.SGD","LU1153585028.USD","LU2420271590.USD","BABU","LU0158827948.USD","SNVDAmain","LU0056508442.USD","LU1989772840.SGD","LU0444971666.USD","LU1992135399.USD","LU0359201885.HKD","LU2637965513.SGD","LU0238689110.USD","LU1645745479.HKD","ARTY","LU0868494617.USD","LU0187121727.USD","LU1282649810.SGD","METV","LU0310799852.SGD","BK4592","SG9999002232.USD","LU2125154778.USD","LU0949170772.SGD","LU2506951792.HKD","LU1934455863.HKD","BK4220","LU0170899867.USD","LU1804176565.USD","IE0001KFT4U8.USD","LU0109391861.USD","LU1316542783.SGD","IE00B1BXHZ80.USD","LU0287142896.SGD","LU0964807845.USD","LU2552382058.USD","LU0708994859.HKD","IE00BKPKM429.USD","IE00BMPRXN33.USD","LU0256863902.USD","LU2244417387.USD","LU2471134952.CNY","IE0034235295.USD","LU1069344957.HKD","THMR","BK4598","HK0000819398.USD","LU0651946864.USD","LU2242650005.HKD","LU2458330169.SGD","FTEC","LU0528227936.USD","TTXU","LU1116320901.HKD","LU0138981039.USD","LU2543165471.USD","LU0181495838.USD","HK0000914686.HKD","LU1366192091.USD","LU2452424414.USD","LU0762541174.USD","LU0097036916.USD","LU0106261372.USD","LU1116320737.USD","LU3063872942.SGD","LU2250418816.HKD","BK4526","IE00BZ199S13.USD","LU0052756011.USD","SG9999014575.USD","SG9999015358.SGD","LU2237957902.USD","LU0823426308.USD","LU1979441026.SGD","LU2089284900.SGD","LU0557290698.USD","LU1923623000.USD","LU0256863811.USD","IE00BF5LJ272.USD","IE00BJJMRY28.SGD","IE00B3S45H60.SGD","LU2125909593.SGD","FPA","IE00BKDWB100.SGD","601869","BK4607","LU0211977185.USD","LU2023251221.USD","BK4587","DIPS","LU0348814723.USD","LU1280957306.USD","LU0820562030.AUD","NVDD","SG9999002224.SGD","LU1951198990.SGD","LU2462591350.SGD","SG9999015978.USD","LU1880383366.USD","BK4549","LU1769817096.USD","LU1642822529.SGD","VT","FAI","89888","LU0039217434.USD","LU2237443895.HKD","LU0516423091.SGD","LFGY","IE00BDRTCR15.USD","IE0004445015.USD","NULC","LU2929501877.USD","01797","01952","LU0359202008.SGD","LU2237438978.USD","BK4612","LU0463099449.HKD","LU1989772923.USD","LU2065169927.USD","LU2065171311.SGD","LU1778281490.HKD","LU1069347547.HKD","LU0234572021.USD","LU1794554557.SGD","NVII","LU0543330566.HKD","LU0472753341.HKD","BABA","IE00BQXX3F31.USD","SG9999014674.SGD","IE00BK4W5L77.USD","LU1046421795.USD","BK4504","IE00B1XK9C88.USD","LU1839511570.USD","BK1618","LU0211327993.USD","LU1720050803.USD","BK4532","LU0308772762.SGD","LU0831093199.SGD","LU0823434583.USD","02268","LU0006306889.USD","XLK","LU1813983027.USD","LU0251132253.USD","LU2133065610.SGD","LU2326559502.SGD","USD","FDTX","LU0289739343.SGD","BK4524","LU0048584097.USD","LU1633808545.USD","LU2430703095.HKD","LU0359201612.USD","LU0957808578.USD","LU1152091168.USD","LU0444973449.USD","LU0070217475.USD","IE00BQXX3D17.EUR","IE00BFMHRM44.USD","LU0140636845.USD","LU1803068979.SGD","BK4535","IE00BFSS7M15.SGD","LU1548497426.USD","LU2361044865.SGD","KURE","LU2462157665.USD","LU2463028550.USD","LU1429558221.USD","IE00BN29S564.USD","LU1670756490.USD","CMAG","LU0918141887.USD","BK4527","IE00B0JY6N72.USD","LU2168564149.EUR","LU2413666699.HKD","BK1191","VGT","LU2417539215.USD","LU2746668974.SGD","LU0738911758.USD","LU0553294199.USD","NVD2.UK","LU2039709279.SGD","LU2750360997.AUD","LU0274383776.USD","LU1515016050.SGD","IE0009G5SDU7.USD","LU2023250504.SGD","LU1261432733.SGD","LU0164865239.USD","LU1481107354.HKD","02269","NVDB","IE0004086264.USD","LU0164880469.USD","LU0314109678.HKD","BK4533","LU1400636574.HKD","LU0320764599.SGD","BK1583","LU0353189680.USD","LU1046422090.SGD","LU0128525929.USD","688331","LU0316494557.USD","LU1674673428.USD","LU0320765059.SGD","LU1969619763.USD","LU0648948544.HKD","LU0588546209.SGD","LU2077746001.SGD","07788","LU2023250330.USD","SG9999015986.USD","LU1721428933.USD","LU2168563687.JPY","LU2462591277.SGD","LU0082616367.USD","BK1588","IXN","BK1615","LU0265550946.USD","LU1105468828.SGD","LU2125909916.SGD","CNEQ","ALBmain","LU0265550359.USD","LU0267386448.USD","LU1066051225.USD","BABW","ABFL","BK1589","LU0390134368.USD","LU2054465674.USD","LU2168564065.EUR","IETC","LU2403377893.USD","LU0965509101.SGD","NVIW.SI","TTEQ","LU2322448791.USD","NVYY","LU2394011477.USD","LU2413666426.HKD","ILDR","LU1914381329.SGD","LU0689472784.USD","IE00BHPRN162.USD","LU1935043023.USD","LU1861127337.USD","LU1003077747.HKD","LU1035773651.USD","LU1718418525.SGD","LU0307460666.USD","LU2087625088.SGD","LU0061474960.USD","SG9999006597.SGD","SG9999017495.SGD","LU0047713382.USD","LU0889565833.HKD","LU0531971595.HKD","GB00BDT5M118.USD","LU2111349929.HKD","NVD3.UK","BK1170","IE00BJTD4N35.SGD","LU0345769631.USD","LU2125154935.USD","IE000YTNTUN2.SGD","LU0985320562.USD","BK4538","JGRO","SMHX","BK1575","LU1861215975.USD","IE00B775SV38.USD","LU2381873111.SGD","LU1868836591.USD","BK4503","LU0149721374.USD","LU2211815571.USD","BK4531","LU1051768304.USD","LU0053666078.USD","LU2106854487.HKD","LU1282649067.USD","LU2237443622.USD","SG9999004303.SGD","BK4588","LU0823421333.USD","LU2237443549.SGD","LU0276348264.USD","LU0080751232.USD","LU2931357623.SGD","LU0128526141.USD","LU0651947912.USD","LU2361045086.USD","LU2028103732.USD","LU2148611432.USD","IE00BJJMRX11.SGD","CHPX","LU1674673691.USD","LU0154236417.USD","LU0210528500.USD","LU1188198961.HKD","02556","LU1037948897.HKD","LU0516422366.SGD","LU1629891620.HKD","LU2089283258.USD","SG9999015945.SGD","BK1144","LU2237443978.SGD","LU1712237335.SGD","WXXWY","IE00BZ1G4Q59.USD","BK1523","LU1720051017.SGD","LU0197773160.USD","LU1868837300.USD","LU0173614495.USD","IE00B3SWFQ91.USD","LU0128525689.USD","BK1509","LU0210533765.USD","LU2954938101.SGD","LU2279689827.SGD","LU2272731782.SGD","SOXX","SG9999018857.SGD","LU1923622291.USD","HK0000532082.HKD","LU1935042215.USD","LU0174119429.USD","SG9999002562.SGD","BK1596","LU2226246903.HKD","LU0630378692.HKD","WISE","IE00BJLML261.HKD","LU0345769128.USD","LU0918141705.HKD","BK1228","LU0719512351.SGD","LU1880398471.USD","LU2778985437.USD","LU0072913022.USD","NVDS.UK","LU1983260115.SGD","LU0323239441.USD","SG9999018865.SGD","LU0501845795.SGD","LU1821325948.USD","LU2756315318.SGD","LU0476273544.USD","LU2322448957.HKD","LU0689626769.HKD","BK4575","BK1141","LU0821914370.USD","IE00BMPRXQ63.HKD","LU0011850046.USD","LU1935042991.SGD","LU2433249047.HKD","LU2592432038.USD","LU0328353924.USD","SG9999000418.SGD","BABX","LU0762542818.HKD","LU0061474705.USD","LU0786609619.USD","HK0000306685.HKD","LU1791710582.SGD","SGXZ81514606.USD","NVDY","BK1610","LU1868836914.USD","3NVD.UK","LU0266013472.USD","LU0348735423.USD","LU0795875086.SGD","LU2430703251.USD","BABC","IE00BJTD4V19.USD","LU1328277881.USD","LU0640476718.USD","002821","IE00B19Z8W00.USD","LU1974910355.USD","LU3102509885.SGD","LU1989764748.USD","LU2168564495.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125425592","title":"CSPC Pharma's Recombinant RSV Vaccine Wins US Clinical Trial Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=1125425592","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125425592?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:18","pubTimestamp":1787656739,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that its preventive biologic Class 1 new drug, the recombinant respiratory syncytial virus (RSV) vaccine (SYS6057), has received approval from the US Food and Drug...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU1807302812.USD","LU1993786604.SGD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","IE0008368742.USD","LU0315179316.USD","LU1960683339.HKD","LU0314109678.HKD","IBBJ","LU1008478684.HKD","KURE","LU1226288170.HKD","LU0140636845.USD","LU1813983027.USD","BK1191","LU1152091754.HKD","LU2039709279.SGD","LU0072913022.USD","01093","LU1226287792.SGD","LU1951186391.HKD","SG9999004220.SGD","MDTX","PSYK","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1515","IE00BZ08YT58.USD","LU0326950275.SGD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU0067412154.USD","LU1152091168.USD","LU1226287529.USD","LU1226287875.USD","LU1328277881.USD","IE0008369823.USD","LU0880133367.SGD","LU0501845795.SGD","LU1226288253.USD","BMED","BK1521","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662373966","title":"CSPC Says FDA Clears RSV Vaccine Candidate SYS 6057 for US Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662373966","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662373966?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:13","pubTimestamp":1787656432,"startTime":"0","endTime":"0","summary":"CSPC says FDA clears RSV vaccine candidate SYS 6057 for US clinical trialCSPC won FDA clearance to start US clinical trials of its recombinant RSV vaccine candidate SYS 6057.China’s NMPA cleared the s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDLbJ9wBp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1813983027.USD","BK1521","BK1515","LU1152091754.HKD","IE0008369823.USD","SG9999004220.SGD","IE00BZ08YT58.USD","IE0008368742.USD","LU1226288253.USD","KURE","LU0880133367.SGD","LU0072913022.USD","LU1226287529.USD","LU1960683339.HKD","LU0501845795.SGD","HK0000165453.HKD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","01093","LU0140636845.USD","LU1951186391.HKD","IE00BZ08YS42.EUR","LU1807302812.USD","LU2039709279.SGD","LU0067412154.USD","LU0315179316.USD","LU1226287792.SGD","LU1328277881.USD","LU0326950275.SGD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU1226288170.HKD","BK1191","LU1993786604.SGD","LU0314109678.HKD","LU1008478684.HKD","LU1152091168.USD","LU1226287875.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662739659","title":"CSPC Pharmaceutical - Recombinant Respiratory Syncytial Virus Vaccine (Sys6057) Obtains Clinical Trial Approval in U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662739659","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662739659?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:13","pubTimestamp":1787656403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0FG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","LU0315179316.USD","LU2039709279.SGD","HK0000165453.HKD","LU0072913022.USD","LU1152091754.HKD","IE00BZ08YS42.EUR","LU0140636845.USD","BK1521","LU1226288253.USD","IE00BZ08YT58.USD","SG9999004220.SGD","IE00B5MMRT66.SGD","LU1807302812.USD","IE00B543WZ88.USD","LU0314109678.HKD","IE00B031HY20.USD","LU0501845795.SGD","01093","LU1328277881.USD","BK1191","LU1226287529.USD","LU1226287875.USD","IE0008368742.USD","LU1226288170.HKD","LU1993786604.SGD","LU1008478684.HKD","LU0067412154.USD","LU0880133367.SGD","LU1813983027.USD","KURE","LU1152091168.USD","IE0008369823.USD","LU0326950275.SGD","LU1960683339.HKD","LU1951186391.HKD","IE00BZ08YR35.GBP","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662396517","title":"CSPC Pharmaceutical - Sys6057 Receives Nmpa Approval on July 30, 2026 to Conduct Clinical Trials in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2662396517","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662396517?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:13","pubTimestamp":1787656403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0FG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1226288253.USD","LU1813983027.USD","LU0314109678.HKD","LU0315179316.USD","IE00B5MMRT66.SGD","IE00B031HY20.USD","LU1328277881.USD","BK1521","LU1951186391.HKD","LU1226287792.SGD","IE0008369823.USD","LU0326950275.SGD","LU1226288170.HKD","LU0501845795.SGD","IE00B543WZ88.USD","LU1807302812.USD","LU1960683339.HKD","LU0880133367.SGD","LU0067412154.USD","LU1152091168.USD","LU1226287529.USD","BK1515","01093","LU1226287875.USD","IE00BZ08YS42.EUR","BK1191","SG9999004220.SGD","KURE","IE00BZ08YT58.USD","LU0140636845.USD","LU2039709279.SGD","HK0000165453.HKD","LU1008478684.HKD","LU1993786604.SGD","LU0072913022.USD","IE0008368742.USD","IE00BZ08YR35.GBP","LU1152091754.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662736664","title":"Innovent Biologics' H1 Profit Jumps 50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662736664","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662736664?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:53","pubTimestamp":1787655233,"startTime":"0","endTime":"0","summary":"Innovent Biologics  recorded over 50% increase in profit in the first half of 2026 to 1.25 billion yuan from 834.3 million yuan a year prior, according to a Tuesday filing with the Hong Kong bourse.Earnings per share climbed to 0.70 yuan from 0.49 yuan in the corresponding period of the last year.Total revenue for the drug company jumped 44.8% to 8.62 billion yuan from 5.95 billion yuan in the year-ago period.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","LU2097828714.EUR","BK1583","LU1969619763.USD","LU0502904849.HKD","LU0244354667.USD","LU2328871848.SGD","LU0326950275.SGD","LU2097828631.EUR","LU2097828474.EUR","LU0455707207.USD","LU2242644610.SGD","LU2488822045.USD","FCA","KURE","HK0000165453.HKD","LU2097828557.USD","01801","LU2097828805.USD","LU1188198961.HKD","LU0463099449.HKD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662667735","title":"Innovent Biologics - Re-Designates Ronald Hao Xi Ede as Non-Executive Director Effective September 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662667735","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662667735?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:30","pubTimestamp":1787653848,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M09K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0244354667.USD","LU2097828557.USD","LU2488822045.USD","LU1969619763.USD","LU2097828631.EUR","01801","LU0326950275.SGD","LU2097828474.EUR","LU1188198961.HKD","HK0000165453.HKD","LU0463099449.HKD","LU0455707207.USD","KURE","LU2097828805.USD","BK1161","LU2328871848.SGD","LU2242644610.SGD","LU2097828714.EUR","BK1583","BK1589","LU0502904849.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735308","title":"WuXi Biologics Posts Higher Adjusted Attributable Profit in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735308","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662735308?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:26","pubTimestamp":1787653596,"startTime":"0","endTime":"0","summary":"WuXi Biologics   reported 3.31 billion yuan in adjusted profit attributable to owners for the first half, compared with 2.39 billion yuan a year ago, a Tuesday bourse filing showed.Adjusted EPS moved to 0.78 yuan from 0.56 yuan year over year.For the six months ended June 30, revenue was 11.8 billion yuan, versus 9.95 billion yuan previously, the biotechnology company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0051755006.USD","LU0823426308.USD","LU0307460666.USD","LU0359202008.SGD","LU0181495838.USD","02269","LU0039217434.USD","LU1242518931.SGD","LU0348735423.USD","FCA","LU2039709279.SGD","BK1141","LU0516422952.EUR","LU1242518857.USD","LU0856984785.SGD","LU0140636845.USD","LU0320764599.SGD","LU1688375341.USD","LU1720050803.USD","LU0348825331.USD","LU1794554557.SGD","LU3063872942.SGD","LU0128526141.USD","BK1610","LU0572944931.SGD","LU0052750758.USD","LU0516422440.USD","LU0979878070.USD","LU0456827905.SGD","BK1589","LU0516423174.USD","KURE","LU0326950275.SGD","LU0516423091.SGD","LU0359201612.USD","LU0516422366.SGD","LU0819121731.USD","BK1521","LU0043850808.USD","IE00B0JY6N72.USD","SG9999002562.SGD","LU0708995583.HKD","LU0029874061.USD","LU0327786744.USD","LU0456846285.SGD","LU0823426480.USD","BK1576","LU0417516902.SGD","SG9999002463.SGD","LU1880383366.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662733267","title":"Innovent Announces 2026 Interim Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2662733267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662733267?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:15","pubTimestamp":1787652900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA2VVLLK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0463099449.HKD","KURE","LU0326950275.SGD","LU2242644610.SGD","LU1969619763.USD","BK1161","LU2097828474.EUR","HK0000165453.HKD","LU2328871848.SGD","BK1583","LU2097828805.USD","LU1188198961.HKD","BK1589","LU0502904849.HKD","01801","LU2488822045.USD","LU0244354667.USD","LU2097828714.EUR","LU2097828631.EUR","LU0455707207.USD","LU2097828557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110441063","title":"INNOVENT BIO Reports First-Half Profit of RMB 1.253 Billion, Up 50.2% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1110441063","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110441063?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:12","pubTimestamp":1787652747,"startTime":"0","endTime":"0","summary":"INNOVENT BIO has announced its interim results for the six months ended June 30, 2026. Measured under International Financial Reporting Standards (IFRS), the company posted total revenue of RMB 8.618...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","HK0000165453.HKD","LU2097828474.EUR","BK1161","LU2328871848.SGD","01801","LU1188198961.HKD","LU2242644610.SGD","LU0502904849.HKD","LU0455707207.USD","LU2488822045.USD","LU2097828631.EUR","LU0463099449.HKD","LU2097828557.USD","BK1583","LU0244354667.USD","KURE","BK1589","LU0326950275.SGD","LU2097828714.EUR","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}